Skip to main content
SpringerLink
Log in

Association and interaction analysis of metabolic syndrome and serum uric acid on diastolic heart failure

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: We aimed to assess the extent to which metabolic syndrome (MetS) and serum uric acid (UA) and its interaction impact on diastolic heart failure (DHF). Materials and methods: A total of 133 patients with DHF and 118 age- and gender-matched control subjects were studied. Echocardiography was used to assess left ventricular (LV) diastolic function. MetS was defined by suggestions of international diabetes federation (IDF, 2005). The association between MetS or UA and DHF was assessed by multivariate logistic regression analysis (MLR) controlling confounders. The interaction between MetS and UA on DHF was assessed by generalized linear model (GLM) and MLR analysis. Results: MetS and UA were independent predictors of DHF after adjustment for all variables (OR=0.833~2.27, OR UA=1.003 and p<0.05 for all). There was an interaction effect of MetS and UA on DHF (OR Int=2.41 ~2.66, p Int<0.05). Conclusion: The findings of the present study suggested that MetS or UA is associated with DHF, and that MetS interacts with UA to impact on DHF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med 2004, 351: 1097–105.

    Article  PubMed  Google Scholar 

  2. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355: 260–9.

    Article  PubMed  Google Scholar 

  3. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355: 251–9.

    Article  PubMed  Google Scholar 

  4. Mogelvang R, Sogaard P, Pedersen SA, et al. Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Circulation 2009, 119: 2679–85.

    Article  PubMed  Google Scholar 

  5. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288: 2709–16.

    Article  PubMed  Google Scholar 

  6. Baldasseroni S, Urso R, Maggioni AP, et al. Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry. Nutr Metab Cardiovasc Dis 2012, 22: 442–8.

    Article  PubMed  Google Scholar 

  7. Alimonda AL, Nunez J, Nunez E, et al. Hyperuricemia in acute heart failure. More than a simple spectator? Eur J Intern Med 2009, 20: 74–9.

    Article  PubMed  Google Scholar 

  8. Dawson J, Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? Br J Clin Pharmacol 2006, 62: 633–44.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Cingolani HE, Plastino JA, Escudero EM, et al. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study. J Card Fail 2006, 12: 491–8.

    Article  PubMed  Google Scholar 

  10. Tsao PS, Niebauer J, Buitrago R, et al. Interaction of diabetes and hypertension on determinants of endothelial adhesiveness. Arterioscler Thromb Vasc Biol 1998, 18: 947–53.

    Article  PubMed  Google Scholar 

  11. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome — a new worldwide definition. Lancet 2005, 366: 1059–62.

    Article  PubMed  Google Scholar 

  12. Dimitrijevic-Sreckovic V, Colak E, Djordjevic P, et al. Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome. Clin Chem Lab Med 2007, 45: 1140–4.

    Article  PubMed  Google Scholar 

  13. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008, 10: 933–89.

    Article  PubMed  Google Scholar 

  14. Peterson LR, Waggoner AD, Schechtman KB, et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 2004, 43: 1399–404.

    Article  PubMed  Google Scholar 

  15. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007, 115: 3213–23.

    Article  PubMed  Google Scholar 

  16. Ouwens DM, Diamant M. Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy. Arch Physiol Biochem 2007, 113: 76–86.

    Article  PubMed  Google Scholar 

  17. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54: 1615–25.

    Article  PubMed  Google Scholar 

  18. de Simone G, Palmieri V, Bella JN, et al. Association of left ventricular hypertrophy with metabolic risk factors: the Hyper GEN study. J Hypertens 2002, 20: 323–31.

    Article  PubMed  Google Scholar 

  19. Widlansky ME, Gokce N, Keaney JF jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003, 42: 1149–60.

    Article  PubMed  Google Scholar 

  20. Santos RD. Uric acid and cardiovascular disease: how to solve another chicken or egg puzzle. Cardiology 2009, 114: 298–9.

    Article  PubMed  Google Scholar 

  21. Santos RD, Nasir K, Orakzai R, et al. Relation of uric acid levels to presence of coronary artery calcium detected by electron beam tomography in men free of symptomatic myocardial ischemia with versus without the metabolic syndrome. Am J Cardiol 2007, 99: 42–5.

    Article  PubMed  Google Scholar 

  22. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006, 37: 1503–7.

    Article  PubMed  Google Scholar 

  23. Strasak A, Ruttmann E, Brant L, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83, 683 Austrian men. Clin Chem 2008, 54: 273–84.

    Article  PubMed  Google Scholar 

  24. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005, 16: 3553–62.

    Article  PubMed  Google Scholar 

  25. Sundstrom J, Sullivan L, D’Agostino RB, et al. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005, 45: 28–33.

    Article  PubMed  Google Scholar 

  26. Cowan BR, Young AA. Left ventricular hypertrophy and renin-angiotensin system blockade. Curr Hypertens Rep 2009, 11: 167–72.

    Article  PubMed  Google Scholar 

  27. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 2005, 25: 39–42.

    Article  PubMed  Google Scholar 

  28. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 2005, 1: 80–6.

    Article  PubMed  Google Scholar 

  29. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003, 42: 474–80.

    Article  PubMed  Google Scholar 

  30. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006, 290: F625–31.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Huashan Hospital of Fudan University, No 12 Wulumuqi Mid Road, Building 0#, Jing’an District, Shanghai, 200040, China

    Z.-H. Tang, Z. Fang, F. Zeng, Z. Li & L. Zhou MD, PhD

Authors
  1. Z.-H. Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z. Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Z. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Zhou MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Zhou MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tang, ZH., Fang, Z., Zeng, F. et al. Association and interaction analysis of metabolic syndrome and serum uric acid on diastolic heart failure. J Endocrinol Invest 36, 579–583 (2013). https://doi.org/10.3275/8851

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/8851

Key-words

Search

Navigation